|
|
|
| home > white papers > Accelerating the Time from DNA to Material - Merck |
|
|
 WHITE PAPERS |
|
Merck
|
|
Accelerating the Time from DNA to Material
|
|
Cell line development is a critical step in upstream process development
for monoclonal antibodies (mAbs). Unfortunately, the search for the
bestproducing clone can be labor- and resource-intensive and is often
compared with looking for a needle in a haystack. Cells must first be
engineered to produce the biologic of interest and the cell line
generated from a high producing clone must deliver a sufficiently high
titer to support clinical studies, and ultimately commercialization of
the therapeutic.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
A new anti-tumour treatment is one step closer to the clinic thanks to a new collaboration between In3Bio and 3P Biopharmaceuticals
[Pamplona, November 26 2019] 3P Biopharmaceuticals,
a leading Contract Development and Manufacturing Organization (CDMO)
specialized in process development and cGMP manufacturing of biologics,
has been chosen by In3Bio, a UK based Biotech company, to collaborate in
the development of a novel anti-tumour treatment.
More info >> |
|
 |
White Papers |
 |
|
Medpace Reference Laboratories establishes state of the art Flow Cytometry techniques for flexible approaches to clinical trials across multiple therapeutic areas.
Medpace
Cytometry is the process of measuring the properties of individual cells. These properties may include gene or protein expression, chemical properties, deoxyribonucleic acid (DNA) content, and various cellular functions. The earliest methods of cytometry relied upon light microscopy for the classification and observation of cells and cellular components. Microscopy permitted direct visual observation of cells for the first time, leading to the classification of cells by morphology and insight into cellular functions. However, the time required for microscopic analysis constrains the number of samples or number of cells in each sample that can be examined. Therefore, the utility of microscopy for analysis of rare cells or in situations where sample throughput is a priority is limited. Flow cytometry was developed largely to improve upon these limitations.
More info >> |
|
 |
Industry Events |
 |
Outsourcing in Clinical Trials Europe
26-27 October 2020, Paris, France
Arena International are delighted to announce the return of Outsourcing
in Clinical Trials Europe. Part of our global series of events, this
flagship show will attract the leading clinical professionals from
across Europe. The 10th Annual event will be hosted in Paris.
More info >> |
|
|
|
